The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
Open accessAbstract
Infectious diseases remain one of the leading causes of morbidity and mortality worldwide. The WHO and CDC have expressed serious concern regarding the continued increase in the development of multidrug resistance among bacteria. Therefore, the antibiotic resistance crisis is one of the most pressing issues in global public health. Associated with the rise in antibiotic resistance is the lack of new antimicrobials. This has triggered initiatives worldwide to develop novel and more effective antimicrobial compounds as well as to develop novel delivery and targeting strategies. Bacteria have developed many ways by which they become resistant to antimicrobials. Among those are enzyme inactivation, decreased cell permeability, target protection, target overproduction, altered target site/enzyme, increased efflux due to over-expression of efflux pumps, among others. Other more complex phenotypes, such as biofilm formation and quorum sensing do not appear as a result of the exposure of bacteria to antibiotics although, it is known that biofilm formation can be induced by antibiotics. These phenotypes are related to tolerance to antibiotics in bacteria. Different strategies, such as the use of nanostructured materials, are being developed to overcome these and other types of resistance. Nanostructured materials can be used to convey antimicrobials, to assist in the delivery of novel drugs or ultimately, possess antimicrobial activity by themselves. Additionally, nanoparticles (e.g., metallic, organic, carbon nanotubes, etc.) may circumvent drug resistance mechanisms in bacteria and, associated with their antimicrobial potential, inhibit biofilm formation or other important processes. Other strategies, including the combined use of plant-based antimicrobials and nanoparticles to overcome toxicity issues, are also being investigated. Coupling nanoparticles and natural-based antimicrobials (or other repurposed compounds) to inhibit the activity of bacterial efflux pumps; formation of biofilms; interference of quorum sensing; and possibly plasmid curing, are just some of the strategies to combat multidrug resistant bacteria. However, the use of nanoparticles still presents a challenge to therapy and much more research is needed in order to overcome this. In this review, we will summarize the current research on nanoparticles and other nanomaterials and how these are or can be applied in the future to fight multidrug resistant bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–250 of 250
Antonelli, M. M., PASCALE, G. D., Ranieri, V. M., Pelaia, P., Tufano, R., Piazza, O., Zangrillo, A., Ferrario, A., Gaetano, A. D., Guaglianone, E., et al. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.07.010 · Cited by 78
Thomas, R., Nair, A. P., Kr, S., et al. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-0852-z · Cited by 77
Bresee, J., Bond, C. M., Worthington, R. J., Smith, C. A., Gifford, J. C., Simpson, C. A., Carter, C. J., Wang, G., Hartman, J., Osbaugh, N. A., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja408505n · Cited by 75
Rai, M., Ingle, A. P., Pandit, R., Paralikar, P., Gupta, I. R., Chaud, M. V., & dos Santos, C. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.127 · Cited by 75
Bacterial Biofilm Control by Perturbation of Bacterial Signaling Processes
Jakobsen, T. H., Tolker‐Nielsen, T., & Givskov, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091970 · Cited by 75
Fakhri, A., Tahami, S., & Naji, M. (2017) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2017.02.014 · Cited by 73
Singh, J., Garg, T., Rath, G., & Goyal, A. K. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1074765 · Cited by 72
El-Azizi, M., Din, S. N. E., El-Tayeb, T. A.-A., & Abou‐Aisha, K. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s102398 · Cited by 70
Chang, T.-Y., Chen, C. C., Cheng, K., Chin, C.-Y., Chen, Y. H., Chen, X. A., Sun, J., Young, J., & Chiueh, T. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.03.054 · Cited by 70
Ramasamy, M., Lee, J., & Lee, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132784 · Cited by 69
Ramasamy, M., Lee, J., & Lee, J. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.10.018 · Cited by 69
Chaurasia, A. K., Thorat, N. D., Tandon, A., Kim, J.-H., Park, S. H., & Kim, K. K. (2016) · Scientific Reports · doi:10.1038/srep33662 · Cited by 67
Choi, S.-R., Britigan, B., Moran, D., & Narayanasamy, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177987 · Cited by 67
Baker, S., Azmath, P., & Satish, S. (2015) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2015.06.011 · Cited by 65
Nanotheranostics of Circulating Tumor Cells, Infections and Other Pathological Features in Vivo
Kim, J.-W., Galanzha, E. I., Zaharoff, D. A., Griffin, R. J., & Zharov, V. P. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300577s · Cited by 64
Shaikh, S., Rizvi, S. M. D., Shakil, S., Hussain, T., Alshammari, T. M., Ahmad, W., Tabrez, S. S. M., Al-Qahtani, M. H., & Abuzenadah, A. M. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25929 · Cited by 64
Multifunctional Nanoplatforms for Targeted Multidrug-Resistant-Bacteria Theranostic Applications
Dai, X., Fan, Z., Lu, Y., & Ray, P. C. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am403567k · Cited by 63
Miao, L., Wang, C., Hou, J., Wang, P., Ao, Y., Li, Y., Geng, N., Yao, Y., Lv, B., Yang, Y., et al. (2016) · Bioresource Technology · doi:10.1016/j.biortech.2016.05.082 · Cited by 62
Laser thermal ablation of multidrug-resistant bacteria using functionalized gold nanoparticles
MOCAN, L. C., Tăbăran, F., Mocan, T., Pop, T., Moșteanu, O., Agoşton-Coldea, L., MATEA, C. T., Gonciar, D., Zdrehuş, C., & Iancu, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s124778 · Cited by 61
Gold-functionalized magnetic nanoparticles restrict growth of Pseudomonas aeruginosa
Car, H., Niemirowicz, K., Święcicka, I., Wilczewska, A. Z., Bienias, K., Bucki, R., Misztalewska‐Turkowicz, I., & Kalska-Szostko, B. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s56588 · Cited by 60
Poma, A. M., & Giorgio, M. D. (2008) · Current Genomics · doi:10.2174/138920208786847962 · Cited by 60
Engineered Nanoparticles with Antimicrobial Property
Reshma, V. G., Syama, S., Sruthi, S., Cherian, R. S., Remya, N. S., & Mohanan, P. V. (2017) · Current Drug Metabolism · doi:10.2174/1389200218666170925122201 · Cited by 60
Chakraborti, S., Mandal, A. K., Sarwar, S., Singh, P., Chakraborty, R., & Chakrabarti, P. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.03.044 · Cited by 59
Functionalised nanoparticles complexed with antibiotic efficiently kill MRSA and other bacteria
Wang, L., Chen, Y. P., Miller, K. P., Cash, B. M., Jones, S. R., Glenn, S., Benicewicz, B. C., & Decho, A. W. (2014) · Chemical Communications · doi:10.1039/c4cc04936e · Cited by 58
MOCAN, L. C., MATEA, C. T., Tăbăran, F., Moșteanu, O., Pop, T., Puia, I. C., Agoşton-Coldea, L., Gonciar, D., Kalman, E., Zaharie, G. C., et al. (2016) · Scientific Reports · doi:10.1038/srep39466 · Cited by 58
JankauskaitL·, V., VitkauskienL·, A., Lazauskas, A., Baltrušaitis, J., ProsyL·evas, I., & AndruleviL·ius, M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.121 · Cited by 52
Recycling Is Not Always Good: The Dangers of Self-Plagiarism
Bonnell, D. A., Buriak, J. M., Hafner, J. H., Hammond, P. T., Hersam, M. C., Javey, A., Kotov, N. A., Nordlander, P. J., Parak, W. J., Rogach, A. L., et al. (2012) · ACS Nano · doi:10.1021/nn3000912 · Cited by 49
Webster, T. J., Leuba, K., Durmus, & Taylor (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s38256 · Cited by 48
Nanotechnology based anti-infectives to fight microbial intrusions
Rai, M., Ingle, A. P., Gaikwad, S. C., Gupta, I. R., Gade, A., & da Silva, S. S. (2015) · Journal of Applied Microbiology · doi:10.1111/jam.13010 · Cited by 48
Nanotheranostic approaches for management of bloodstream bacterial infections
Jagtap, P., Sritharan, V., & Gupta, S. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.09.005 · Cited by 45
Regassa, B. T., Endale, A., & Bekele, D. (2017) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-017-0241-x · Cited by 45
D-alanyl-D-alanine-Modified Gold Nanoparticles Form a Broad-Spectrum Sensor for Bacteria
Yang, X., Dang, Y., Lou, J., Shao, H., & Jiang, X. (2018) · Theranostics · doi:10.7150/thno.22540 · Cited by 45
Zhang, Y., Zhu, P., Li, G., Wang, W., Chen, L., Lu, D. D., Sun, R., Zhou, F., & Wong, C. (2015) · Nanoscale · doi:10.1039/c5nr03414k · Cited by 41
Gold–silver-alloy nanoprobes for one-pot multiplex DNA detection
Dória, G., Larguinho, M., Dias, J. T., Pereira, E., Franco, R., & Baptista, P. V. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/25/255101 · Cited by 40
Self-citationKuo, Y.-L., Wang, S.-G., Wu, C.-Y., Lee, K.-C., Jao, C.-J., Chou, S.-H., & Chen, Y. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0232 · Cited by 40
Enhancement of antibiotic effect via gold:silver-alloy nanoparticles
dos Santos, M. M., Queiroz, M. J., & Baptista, P. V. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-0859-8 · Cited by 39
Self-citationOrtega, A., Farah, S., Tranque, P., Ocaña, A. V., Nam‐Cha, S. H., Beyth, N., Gómez‐Roldán, C., Pérez‐Tanoira, R., Domb, A. J., Pérez‐Martínez, F. C., et al. (2015) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2014.0078 · Cited by 38 · cited 1×
“The bacterial membrane may be disturbed by the charged quaternary moiety, it also has potent activity against a series of Gram-positive and -negative pathogens (Ortega et al., 2015).”
BackgroundUlloa-Ogaz, A. L., Piñón-Castillo, H. A., Castellanos, L., Athie-García, M. S., Ballinas‐Casarrubias, L., Murillo-Ramirez, J. G., Flores-Ongay, L. Á., Duran, R., & Orrantia‐Borunda, E. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-9718-6 · Cited by 36
Use of Nanoparticles as Therapy for Methicillin-Resistant Staphylococcus aureus Infections
Liu, P., Lo, C., Chen, C., Hsieh, M., & Huang, C. (2009) · Current Drug Metabolism · doi:10.2174/138920009790274522 · Cited by 34
Superior antibacterial activity of GlcN-AuNP-GO by ultraviolet irradiation
Govindaraju, S., Samal, M., & Yun, K. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.06.052 · Cited by 34
Assessment of orally dosed commercial silver nanoparticles on humanex vivoplatelet aggregation
Smock, K. J., Schmidt, R. L., Hadlock, G. C., Stoddard, G., Grainger, D. W., & Munger, M. A. (2013) · Nanotoxicology · doi:10.3109/17435390.2013.788749 · Cited by 32
Thompson, M. E., Blaszykowski, C., Sheikh, S., & Romaschin, A. D. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.07.008 · Cited by 31
Antibacterial activity of gold nanoparticles and their toxicity assessment
Umamaheswari, K., Baskar, R., Chandru, K., Rajendiran, N., & Chandirasekar, S. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-s3-p64 · Cited by 27
Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems
Leucuta, S. E. (2013) · Current Drug Delivery · doi:10.2174/1567201811310020007 · Cited by 26
Gene Silencing Using Multifunctionalized Gold Nanoparticles for Cancer Therapy
Fernandes, A. R., & Baptista, P. V. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6646-2_19 · Cited by 26
Self-citationSukwong, P., Somkid, K., Kongseng, S., Pissuwan, D., & Yoovathaworn, K. (2016) · Micro & Nano Letters · doi:10.1049/mnl.2015.0523 · Cited by 21
Impact of pectin esterification on the antimicrobial activity of nisin‐loaded pectin particles
Krivorotova, T., Stanevičienė, R., Lukša, J., Servienė, E., & Sereikaitė, J. (2016) · Biotechnology Progress · doi:10.1002/btpr.2391 · Cited by 20
Testing nanoeffect onto model bacteria: Impact of speciation and genotypes
Gélabert, A., Sivry, Y., Gobbi, P., Mansouri-Guilani, N., Menguy, N., Brayner, R., Siron, V., Benedetti, M. F., & Ferrari, R. (2015) · Nanotoxicology · doi:10.3109/17435390.2015.1048323 · Cited by 13
Lee, W., Hsieh, T.-C., Shiau, J. C., Ou, T.-Y., Chen, F.-L., Liu, Y.-H., Yen, M., & Hsueh, P. (2016) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2016.04.008 · Cited by 13
(2014) · PubMed Central
Cited by
Silver Nanoparticles and Their Antibacterial Applications
Bruna, T., Maldonado-Bravo, F., Jara, P., & Caro, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137202 · Cited by 1,708
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
Makabenta, J. M. V., Nabawy, A., Li, C.-H., Schmidt-Malan, S., Patel, R., & Rotello, V. M. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0420-1 · Cited by 1,397
Bactericidal and Cytotoxic Properties of Silver Nanoparticles
Liao, C., Li, Y., & Tjong, S. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020449 · Cited by 1,059
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
Lee, N.-Y., Ko, W.-C., & Hsueh, P.-R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01153 · Cited by 532
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
Catalano, A., Iacopetta, D., Ceramella, J., Scumaci, D., Giuzio, F., Saturnino, C., Aquaro, S., Rosano, C., & Sinicropi, M. S. (2022) · Molecules · doi:10.3390/molecules27030616 · Cited by 450
Metadata
- Authors
- Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A. R.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2018-07-02
- Volume
- 9
- Pages
- 1441-1441
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2808711858
- Cited by
- 881
- References
- 250
- FWCI
- 28.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.